Ecorem Healthcare Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 23-06-2024
- Paid Up Capital ₹ 2.45 M
as on 23-06-2024
- Company Age 12 Year, 6 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.20 M
as on 23-06-2024
- Revenue -38.91%
(FY 2020)
- Profit -41.33%
(FY 2020)
- Ebitda -261.59%
(FY 2020)
- Net Worth 10.26%
(FY 2020)
- Total Assets -7.28%
(FY 2020)
About Ecorem Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 2.45 M.
The company currently has active open charges totaling ₹1.20 M.
Yashvanth Nagesha and Yelavala Srinivas serve as directors at the Company.
- CIN/LLPIN
U24239KA2012PTC067288
- Company No.
067288
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Dec 2012
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Mysore, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Ecorem Healthcare Private Limited offer?
Ecorem Healthcare Private Limited offers a wide range of products and services, including Nutraceuticals, Nutritional Supplements, Pharmaceutical Syrup, Anti Fever Syrup, Common Disease Medicines, Multivitamin Syrup & Drops, Iron Folic Acid Syrup.
Who are the key members and board of directors at Ecorem Healthcare?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yelavala Srinivas  | Managing Director | 17-Dec-2012 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Yashvanth Nagesha | Director | 21-Oct-2022 | Current |
Financial Performance of Ecorem Healthcare.
Ecorem Healthcare Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 38.91% decrease. The company also saw a substantial fall in profitability, with a 41.33% decrease in profit. The company's net worth Soared by an impressive increase of 10.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ecorem Healthcare?
In 2018, Ecorem Healthcare had a promoter holding of 53.31% and a public holding of 46.69%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of Mysore Creation Date: 24 Feb 2014 | ₹1.20 M | Open |
How Many Employees Work at Ecorem Healthcare?
Unlock and access historical data on people associated with Ecorem Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ecorem Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ecorem Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
